Clinical, Immunological, and Genetic Findings in Iranian Patients with MHC-II Deficiency: Confirmation of c.162delG RFXANK Founder Mutation in the Iranian Population
Mohadese Sadat Mousavi Khorshidi, Yoann Seeleuthner, Zahra Chavoshzadeh, Maryam Behfar, Amir Ali Hamidieh, Hosein Alimadadi, Roya Sherkat, Tooba Momen, Nasrin Behniafard, Shabnam Eskandarzadeh, Mahboubeh Mansouri, Mahdiyeh Behnam, Mohadese Mahdavi, Maryam Heydarazad Zadeh, Mehdi Shokri, Fatemeh Alizadeh, Mahshid Movahedi, Mana Momenilandi, Mohammad Keramatipour, Jean‐Laurent Casanova, Aurélie Cobat, Laurent Abel, Mohammad Shahrooei, Nima Parvaneh
Topics & Concepts
ConsanguinityMedicinePediatricsPopulationHematopoietic stem cell transplantationNewborn screeningFailure to thriveImmunologyCommon variable immunodeficiencyPrimary immunodeficiencyImmunodeficiencyTransplantationInternal medicineImmune systemAntibodyEnvironmental healthImmunodeficiency and Autoimmune DisordersT-cell and B-cell ImmunologyBlood disorders and treatments